Status:
COMPLETED
Computertomography-guided Wire Marking of the Liver
Lead Sponsor:
Medical University of Graz
Conditions:
Secondary Malignant Neoplasm of Liver
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to evaluate if it is possible to mark with a wire colorectal hepatic metastases after complete response to a neoadjuvant chemotherapy.Primary the investigators want to investig...
Detailed Description
Colorectal Cancer is most common in western countries. In 2007 in Austria 4462 new colorectal cancers were diagnosed. The most common place of metastasis is the liver. Approximately 15% of patients ha...
Eligibility Criteria
Inclusion
- Histologic verified cancer of the colon and rectum with metastases into the liver
- Neoadjuvant chemotherapy with complete radiologic response of metastases in apparative diagnostic respectively metastases with a diameter ≤ 1 cm.
- Technically Resectability
- Age ≥ 18 Years
- Written informed consent
Exclusion
- Age \< 18 Years
- Technically Irresectability
- Neoadjuvant chemotherapy and response of metastases, however with a diameter \> 1 cm.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01457599
Start Date
July 1 2011
End Date
August 1 2016
Last Update
August 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery
Graz, Styria, Austria, 8036